These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 24715280

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multivalent DNA-based vectors for DNA vaccine delivery.
    Roh YH, Lee K, Ye JJ, Luo D.
    Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene-based vaccines: recent technical and clinical advances.
    Ulmer JB, Wahren B, Liu MA.
    Trends Mol Med; 2006 May; 12(5):216-22. PubMed ID: 16621717
    [Abstract] [Full Text] [Related]

  • 5. Development of antibiotic-free selection system for safer DNA vaccination.
    Luke JM, Carnes AE, Williams JA.
    Methods Mol Biol; 2014 May; 1143():91-111. PubMed ID: 24715283
    [Abstract] [Full Text] [Related]

  • 6. Targeting plasmid-encoded proteins to the antigen presentation pathways.
    Leifert JA, Rodriguez-Carreno MP, Rodriguez F, Whitton JL.
    Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
    [Abstract] [Full Text] [Related]

  • 7. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
    Reimann J, Schirmbeck R.
    Dev Biol (Basel); 2000 Jun; 104():15-24. PubMed ID: 11713813
    [Abstract] [Full Text] [Related]

  • 8. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.
    Cancer Res; 2001 Aug 15; 61(16):6178-84. PubMed ID: 11507070
    [Abstract] [Full Text] [Related]

  • 9. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.
    Cong H, Gu QM, Yin HE, Wang JW, Zhao QL, Zhou HY, Li Y, Zhang JQ.
    Vaccine; 2008 Jul 23; 26(31):3913-21. PubMed ID: 18555564
    [Abstract] [Full Text] [Related]

  • 10. Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.
    Iurescia S, Fioretti D, Fazio VM, Rinaldi M.
    Biotechnol Adv; 2012 Jul 23; 30(1):372-83. PubMed ID: 21745560
    [Abstract] [Full Text] [Related]

  • 11. A blueprint for DNA vaccine design.
    Iurescia S, Fioretti D, Rinaldi M.
    Methods Mol Biol; 2014 Jul 23; 1143():3-10. PubMed ID: 24715278
    [Abstract] [Full Text] [Related]

  • 12. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
    Meerak J, Wanichwecharungruang SP, Palaga T.
    Vaccine; 2013 Jan 21; 31(5):784-90. PubMed ID: 23228812
    [Abstract] [Full Text] [Related]

  • 14. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA, Goletz TJ, Gunn GR, Shi FF, Harris MC, Cochlin K, McCauley C, McCarthy SG, Branigan PJ, Knight DM.
    Vaccine; 2006 Apr 12; 24(16):3340-52. PubMed ID: 16472547
    [Abstract] [Full Text] [Related]

  • 15. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D.
    Vaccine; 2009 May 11; 27(21):2804-11. PubMed ID: 19428891
    [Abstract] [Full Text] [Related]

  • 16. Immunology of DNA vaccines: CpG motifs and antigen presentation.
    Manders P, Thomas R.
    Inflamm Res; 2000 May 11; 49(5):199-205. PubMed ID: 10893042
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT, Umetsu DT, DeKruyff RH, Levy S.
    J Immunol; 1998 Dec 15; 161(12):6532-6. PubMed ID: 9862678
    [Abstract] [Full Text] [Related]

  • 18. Identification of T cell epitopes of Mycobacterium tuberculosis with biolistic DNA vaccination.
    Nagata T, Koide Y.
    Methods Mol Biol; 2013 Dec 15; 940():285-303. PubMed ID: 23104350
    [Abstract] [Full Text] [Related]

  • 19. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D, Dubey S, Van Veldhuizen P, Holzbeierlein JM, Tawfik O, Thrasher JB.
    Immunotherapy; 2011 Jun 15; 3(6):735-46. PubMed ID: 21668311
    [Abstract] [Full Text] [Related]

  • 20. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
    Schirmbeck R, Reimann J.
    Biol Chem; 2001 Apr 15; 382(4):543-52. PubMed ID: 11405219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.